Related Experiment Video

Updated: Jun 26, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Targeted and armed oncolytic poxviruses: a novel multi-mechanistic therapeutic class for cancer

David H Kirn1, Steve H Thorne

  • 1Jennerex Biotherapeutics Inc., San Francisco, California 94105, USA . dkirn@jennerex.com

Nature Reviews. Cancer
|December 24, 2008
PubMed

Insights

Engineered oncolytic poxviruses offer a novel cancer therapy approach. These viruses combine targeted and armed strategies, showing potent and selective systemic cancer treatment in early studies.

Area of Science:

  • Virology
  • Oncology
  • Gene Therapy

Background:

  • Traditional viral cancer therapies like gene therapy vectors, vaccines, and oncolytic viruses have faced limitations in clinical efficacy.
  • These limitations stem from various factors affecting their effectiveness in treating cancer.

Purpose of the Study:

  • To introduce a new class of oncolytic poxviruses engineered for enhanced cancer therapy.
  • To highlight the combined targeted and armed strategies employed by these novel viruses.

Main Methods:

  • Development of a new therapeutic class of oncolytic poxviruses.
  • Engineering viruses with combined targeted and armed approaches for cancer treatment.

Main Results:

  • Initial preclinical and clinical data demonstrate systemic targeting of cancers.
  • These viruses exhibit high selectivity and potency against tumors.
  • A multi-pronged mechanism of action contributes to their therapeutic effect.

Conclusions:

  • The new class of oncolytic poxviruses represents a promising advancement in cancer therapy.
  • These engineered viruses show potential for effective and targeted systemic cancer treatment.

More Related Videos

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats08:55

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats

Published on: April 15, 2016

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy08:51

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...